Skip to main content

Table 1 Antibodies used for immunohistochemical staining and its results

From: Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature

Antigen Antibodies Results
  Clone Source Dilution Biopsy Hysterectomy
      Adenoca. Sarscomatous component
AE1/AE3 AE1/AE3 Dako, Glostrup, Denmark 1: 50 + +++ -
CAM5.2 CAM5.2 BD Biosciences, California, USA 1: 2 ND* +++ -
vimentin V9 Dako 1: 100 +++ - +++
ER SP1 Roche Diagnostics, Basel, Switzerland 1: 1 - - -
PgR 1E2 Roche Diagnostics 1: 1 - - -
AR AR441 Dako 1: 50 ND* - -
CD10 56C6 Leica Microsystems, Newcastle, UK 1: 40 - ++ ++
calretinin 5A5 Leica Microsystems 1: 100 - + -
  1. ND*, not done.
  2. Immunopositivity was semi-quantitatively assessed as follows: 3+, more than 10% of the tumor cells positive; 2+, 1-10% of the tumor cells positive; 1+, less than 1% tumor cells positive; no tumor cell staining was considered negative.